Endocrinology GLP-1R Agonists in the Treatment of Diabetes Mellitus: Reducing Serious ComorbiditiesTriple Combination Therapy of CDK4/6 Inhibitors, Endocrine Therapy, and mTOR/PI3K Inhibitors to Treat Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer with Acquired ResistanceThe Potential Use of CDK7 Inhibitors to Treat Metastatic Castration-Resistant Prostate Cancer via Reduction in MED1 Phosphorylation and Androgen Receptor Signaling.In Pancreatic Islets from Type 2 Diabetes Patients, the Dampened Circadian Oscillators Lead to Reduced Insulin and Glucagon ExocytosisProtein C and its Interaction with YB-1 as a Potential Therapeutic in Diabetic Cardiomyopathy Caused by Hyperglycemia Induced Oxidative StressTargeting the PI3K/AKT/mTOR Pathway to Overcome Resistance to Endocrine Therapy and CDK4/6 Inhibitors in Estrogen Receptor-Positive Metastatic Breast CancerThe Impact of SGLT 2 Inhibitors on Calcium Cycling and Fibrosis in Cardiac Tissues of Patients with Type 2 Diabetes Mellitus and Heart FailureAn Application of Mesenchymal Stem Cell-derived Extracellular Vesicles in the Reduction of Proinflammatory Signaling via Delivery of miRNA-126 in the Progression of Diabetic RetinopathyAcetylation and Activation of AR K609 and ACK1 Promote Resistance to Androgen Receptor Antagonists in Castration-Resistant Prostate CancerEffects of the FKBP5 Gene on Glucocorticoid Receptors in Relation to Major Depressive Disorder